UNSPSC 51294407: Metoxepin

This classification denotes an antidepressant agent with the molecular formula C20H22N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Z8EZK2DSIT, chemically known as 1-(8-methoxydibenz(b,f)oxepin-10-yl)-4-methylpiperazine but generally known as metoxepin, which bears US NIH Compound Identifier 32226. European Medicines Agency schedules Metoxepin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08913MIG.

UNSPSC 51294407 Metoxepin, a Commodity code, does not map meaningfully to the recent state and local procurement activity tagged under it. The three most recent opportunities solicited under this code address naloxone procurement, therapeutic pharmacy initiatives involving direct-to-manufacturer prescription programs, and generic multi-source pharmaceuticals and OTC products distributed through authorized wholesalers—none of which concern metoxepin specifically. The code shows little relevant recent activity aligned with its nominal pharmaceutical scope.

The mismatch between the code's name and the actual solicitations suggests either tagging inconsistency in the source database or that metoxepin as a discrete commodity sees minimal state and local procurement volume at present. Business development professionals monitoring this code should verify whether opportunities of genuine interest are being tagged under alternate UNSPSC classifications, particularly those addressing pharmaceutical procurement, naloxone supply, or OTC product distribution.